These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26780424)

  • 1. Current advances in therapies for calcium pyrophosphate crystal arthritis.
    Sivera F; Andrés M; Pascual E
    Curr Opin Rheumatol; 2016 Mar; 28(2):140-4. PubMed ID: 26780424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?
    Pascual E; Andrés M; Sivera F
    Arthritis Res Ther; 2015 Apr; 17(1):89. PubMed ID: 25885915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for CPPD: Options and Evidence.
    Andrés M; Sivera F; Pascual E
    Curr Rheumatol Rep; 2018 Apr; 20(6):31. PubMed ID: 29675606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis.
    Moltó A; Ea HK; Richette P; Bardin T; Lioté F
    Joint Bone Spine; 2012 Dec; 79(6):621-3. PubMed ID: 22658375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal arthritis: calcium pyrophosphate deposition-nothing 'pseudo' about it!
    Rosenthal AK; Ryan LM
    Nat Rev Rheumatol; 2011 May; 7(5):257-8. PubMed ID: 21532639
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature.
    Ottaviani S; Brunier L; Sibilia J; Maurier F; Ardizzone M; Wendling D; Gill G; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2013 Mar; 80(2):178-82. PubMed ID: 23022422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of articular chondrocalcinosis--role of ANKH.
    Abhishek A; Doherty M
    Nat Rev Rheumatol; 2011 Feb; 7(2):96-104. PubMed ID: 21102543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium pyrophosphate dihydrate crystal induced arthropathy].
    Announ N; Guerne PA
    Rev Med Suisse; 2007 Mar; 3(103):740-2, 744, 746. PubMed ID: 17458152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium pyrophosphate deposition disease: clinical manifestations.
    Ferrone C; Andracco R; Cimmino MA
    Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on calcium pyrophosphate deposition.
    Abhishek A; Doherty M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):32-8. PubMed ID: 27586801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1β blockade improves signs and symptoms of chronic calcium pyrophosphate crystal arthritis resistant to treatment.
    Diamantopoulos AP; Brodin C; Hetland H; Haugeberg G
    J Clin Rheumatol; 2012 Sep; 18(6):310-1. PubMed ID: 22832289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium pyrophosphate deposition disease: a review of epidemiologic findings.
    Abhishek A
    Curr Opin Rheumatol; 2016 Mar; 28(2):133-9. PubMed ID: 26626724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium pyrophosphate dihydrate crystal deposition and other crystal deposition diseases.
    Pritzker KP
    Curr Opin Rheumatol; 1994 Jul; 6(4):442-7. PubMed ID: 8068517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of calcium pyrophosphate crystal deposition disease: A systematic review.
    Parperis K; Papachristodoulou E; Kakoullis L; Rosenthal AK
    Semin Arthritis Rheum; 2021 Feb; 51(1):84-94. PubMed ID: 33360232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis.
    Andres M; Sivera F; Pascual E
    J Clin Rheumatol; 2012 Aug; 18(5):234-6. PubMed ID: 22832286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium crystal-associated arthritides.
    Rosenthal AK
    Curr Opin Rheumatol; 1998 May; 10(3):273-7. PubMed ID: 9608333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium pyrophosphate deposition (CPPD) disease - Treatment options.
    Stack J; McCarthy G
    Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101720. PubMed ID: 34756508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating difficult crystal pyrophosphate dihydrate deposition disease.
    Announ N; Guerne PA
    Curr Rheumatol Rep; 2008 Jul; 10(3):228-34. PubMed ID: 18638432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes.
    Chang CC; Lee KL; Chan TS; Chung CC; Liang YC
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.
    Fam AG
    Curr Opin Rheumatol; 1992 Aug; 4(4):574-82. PubMed ID: 1503884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.